文献速递慢阻肺

慢性阻塞性肺疾病的遗传学:理解复杂疾病的病理生物学与异质性

Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder.
PubMed 文献 · Lancet Respir Med · 2022-04-12

慢性阻塞性肺疾病(COPD)易感性和异质性无法完全由吸烟等环境因素解释。基于家系和人群的研究表明,相当比例的COPD风险与遗传变异相关。遗传关联研究已发现数百个影响COPD风险、肺功能下降及其他COPD相关特征的遗传变异,这些变异与肺内外特征相关,为COPD异质性提供了遗传基础,对整体COPD风险有实质性影响,提示生命早期事件在发病中的作用,且常涉及先前未怀疑与COPD有关的基因。

要点

  • COPD风险中相当比例与遗传变异相关,不能仅归因于吸烟等环境因素。
  • 已发现数百个遗传变异影响COPD风险、肺功能下降等特征,并解释部分异质性。
  • 遗传变异常涉及新基因,提示生命早期事件在COPD发病中的作用。

核心结论

  • COPD易感性和异质性部分由遗传变异解释,遗传学研究有助于理解病理生物学并开发新的管理治疗策略。

研究设计与样本

  • 基于家系和人群的研究表明COPD风险与遗传变异相关;遗传关联研究已识别数百个遗传变异。

主要发现

  • 数百个遗传变异影响COPD风险、肺功能下降及其他COPD相关特征。
  • 这些变异与其他肺部和肺外特征相关,为COPD异质性提供遗传基础。
  • 遗传变异对COPD总体风险有实质性影响,并常涉及先前未怀疑与COPD有关的基因。
  • 遗传变异提示生命早期事件参与COPD发病机制。

局限性

  • 需要更大规模、更多祖先多样性的遗传研究,改进罕见变异分析及统计方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic obstructive pulmonary disease (COPD) is a deadly and highly morbid disease. Susceptibility to and heterogeneity of COPD are incompletely explained by environmental factors such as cigarette smoking. Family-based and population-based studies have shown that a substantial proportion of COPD risk is related to genetic variation. Genetic association studies have identified hundreds of genetic variants that affect risk for COPD, decreased lung function, and other COPD-related traits. These genetic variants are associated with other pulmonary and non-pulmonary traits, demonstrate a genetic basis for at least part of COPD heterogeneity, have a substantial effect on COPD risk in aggregate, implicate early-life events in COPD pathogenesis, and often involve genes not previously suspected to have a role in COPD. Additional progress will require larger genetic studies with more ancestral diversity, improved profiling of rare variants, and better statistical methods. Through integration of genetic data with other omics data and comprehensive COPD phenotypes, as well as functional description of causal mechanisms for genetic risk variants, COPD genetics will continue to inform novel approaches to understanding the pathobiology of COPD and developing new strategies for management and treatment.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Cho MH, Hobbs BD, Silverman EK, et al. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. Lancet Respir Med. 2022. PMID: 35427534. doi:10.1016/S2213-2600(21)00510-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。